Journal articles on the topic 'Fingolimod hydrochloride'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 21 journal articles for your research on the topic 'Fingolimod hydrochloride.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Kaduk, James A., Kai Zhong, Amy M. Gindhart, and Thomas N. Blanton. "Crystal structure of fingolimod hydrochloride, C19H34ClNO2." Powder Diffraction 30, no. 3 (August 12, 2015): 205–10. http://dx.doi.org/10.1017/s0885715615000317.
Swain, Jitendriya, Santosh R. Borkar, Indrapal Singh Aidhen, and Ashok Kumar Mishra. "A molecular level understanding of interaction between FTY720 (Fingolimod hydrochloride) and DMPC multilamellar vesicles." RSC Adv. 4, no. 33 (2014): 17347–53. http://dx.doi.org/10.1039/c4ra02404d.
Ganhadeiro, Flaviane Maximino Bitencourt, Carla Resende Vaz Oliveira, and Bruno Cezario Costa Reis. "O benefício do uso de fingolimode em pacientes portadores de Esclerose Múltipla." Revista Eletrônica Acervo Médico 23, no. 4 (April 15, 2023): e12504. http://dx.doi.org/10.25248/reamed.e12504.2023.
Balasubramaniam, Sivaraman, Ganapathy Sankaran, and Sneh Badle. "Perspective on FTY720, an Immunosuppressant." Synthesis 50, no. 05 (January 24, 2018): 968–83. http://dx.doi.org/10.1055/s-0036-1591877.
Hussar, Daniel A., and David E. Zimmerman. "New drugs: Dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate." Journal of the American Pharmacists Association 51, no. 1 (January 2011): 122–26. http://dx.doi.org/10.1331/japha.2011.11506.
Vinigari, Krishna, Krishna Jonnada, Noorjahan Mohammed, and Girija Mangatayaru Kotu. "An alternative efficient approach for the synthesis of Fingolimod hydrochloride." Synthetic Communications 49, no. 1 (January 2, 2019): 39–48. http://dx.doi.org/10.1080/00397911.2018.1536788.
Thomas, Katja, Undine Proschmann, and Tjalf Ziemssen. "Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis." Expert Opinion on Pharmacotherapy 18, no. 15 (September 4, 2017): 1649–60. http://dx.doi.org/10.1080/14656566.2017.1373093.
Ward, Melanie D., David E. Jones, and Myla D. Goldman. "Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis." Expert Opinion on Drug Safety 13, no. 7 (June 16, 2014): 989–98. http://dx.doi.org/10.1517/14740338.2014.920820.
Tamakuwala, Mayurkumar, Warren Ratna, Amit Joshi, and Grazia Stagni. "Fingolimod hydrochloride gel shows promising therapeutic effects in a mouse model of atopic dermatitis." Journal of Pharmacy and Pharmacology 68, no. 10 (July 27, 2016): 1268–77. http://dx.doi.org/10.1111/jphp.12588.
Suresh Kumar, Ramdoss, Hariram Balasubramanian, Kalyanaraman Lakshminarayanan, Srinivasu K. Mullapudi, Katkam Srinivas, and Rajeswar Reddy Sagyam. "A systematic approach for reversed phase liquid chromatographic method development of fingolimod hydrochloride via design augmentation." Arabian Journal of Chemistry 12, no. 8 (December 2019): 3289–301. http://dx.doi.org/10.1016/j.arabjc.2015.08.012.
Wang, Jian-Rong, Sha Li, Bingqing Zhu, and Xuefeng Mei. "Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720)." Journal of Pharmaceutical and Biomedical Analysis 109 (May 2015): 45–51. http://dx.doi.org/10.1016/j.jpba.2015.02.018.
Chiba, Kenji, and Narihiko Yoshii. "Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera^|^reg;/Gilenya^|^reg;) for the treatment of multiple sclerosis." Folia Pharmacologica Japonica 139, no. 6 (2012): 265–74. http://dx.doi.org/10.1254/fpj.139.265.
Swain, Jitendriya, Monalisa Mohapatra, Santosh R. Borkar, Indrapal Singh Aidhen, and Ashok Kumar Mishra. "Study of aqueous phase aggregation of FTY720 (fingolimod hydrochloride) and its effect on DMPC liposomes using fluorescent molecular probes." Physical Chemistry Chemical Physics 15, no. 41 (2013): 17962. http://dx.doi.org/10.1039/c3cp53148a.
Tamakuwala, M., and G. Stagni. "Fingolimod Hydrochloride Gel for Dermatological Applications: Optimization of Formulation Strength and Effect of Colloidal Oatmeal (Aveeno®) as Penetration Enhancer." AAPS PharmSciTech 17, no. 4 (September 29, 2015): 907–14. http://dx.doi.org/10.1208/s12249-015-0415-9.
Takasaki, Teruaki, Kanako Hagihara, Ryosuke Satoh, and Reiko Sugiura. "More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis." Oxidative Medicine and Cellular Longevity 2018 (March 28, 2018): 1–13. http://dx.doi.org/10.1155/2018/4397159.
Rajan, N., and K. Anver Basha. "Rapid Determination of Fingolimod Hydrochloride-Related Substances and Degradation Products in API and Pharmaceutical Dosage Forms by Use of a Stability-Indicating UPLC Method." Chromatographia 77, no. 21-22 (October 15, 2014): 1545–52. http://dx.doi.org/10.1007/s10337-014-2751-4.
Ostroumova, O. D., M. S. Cherniaeva, D. I. Bakhteeva, N. A. Arablinskiy, and D. A. Sychyov. "Some groups of drugs which use is associated with development of drug-induced atrial fibrillation." Medical alphabet 1, no. 11 (June 15, 2021): 20–28. http://dx.doi.org/10.33667/2078-5631-2021-11-20-28.
Buylova, I. A., N. G. Sakhno, G. M. Bulgakova, and O. V. Gunar. "ELIMINATION OF FALSE RESULTS OF MEDICINES MICROBIOLOGICAL TESTING." Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 8, no. 3 (September 26, 2018): 187–92. http://dx.doi.org/10.30895/1991-2919-2018-8-3-187-192.
"New drugs: Fingolimod hydrochloride." Australian Prescriber 34, no. 5 (October 1, 2011): 153–59. http://dx.doi.org/10.18773/austprescr.2011.081.
Hussain, Afzal, Ashfaq Hussain, and Chandan Kumar Verma. "COVID-19 infection: A review of summarized Clinical trials study for the treatment." Coronaviruses 01 (September 25, 2020). http://dx.doi.org/10.2174/2666796701999200925204309.
Ye, Min, Yongkang Gai, Hao Ji, Yaqun Jiang, Pengxin Qiao, Wenxia Wang, Yongxue Zhang, Xiaotian Xia, and Xiaoli Lan. "A Novel Radioimmune 99mTc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An In Vitro and In Vivo Study." Frontiers in Immunology 12 (August 18, 2021). http://dx.doi.org/10.3389/fimmu.2021.660842.